(3,5-Diiodo-Tyr5)-LHRH, also known as a modified form of Luteinizing Hormone-Releasing Hormone (LHRH), is a synthetic peptide that features two iodine atoms substituted at the 3 and 5 positions of the tyrosine residue at the fifth position of the peptide sequence. This modification enhances its biological activity and stability. LHRH is a key hormone in the regulation of the reproductive system, stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. The diiodination of the tyrosine residue can influence the peptide's binding affinity to its receptor and its overall pharmacokinetic properties. Typically, such modifications are explored for therapeutic applications, including hormone-related disorders and certain cancers. The CAS number 73644-49-2 uniquely identifies this compound in chemical databases, facilitating its study and application in research and clinical settings. As with many peptides, its stability, solubility, and bioactivity are critical factors in its potential use in medical therapies.

(3,5-Diiodo-Tyr5)-LHRH

73644-49-2: (3,5-Diiodo-Tyr5)-LHRH, also known as a modified form of Luteinizing Hormone-Releasing Hormone (LHRH), is a synthetic peptide that features two iodine atoms substituted at the 3 and 5 positions of the tyrosine residue at the fifth position of the peptide sequence. This modification enhances its biological activity and stability. LHRH is a key hormone in the regulation of the reproductive system, stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. The diiodination of the tyrosine residue can influence the peptide's binding affinity to its receptor and its overall pharmacokinetic properties. Typically, such modifications are explored for therapeutic applications, including hormone-related disorders and certain cancers. The CAS number 73644-49-2 uniquely identifies this compound in chemical databases, facilitating its study and application in research and clinical settings. As with many peptides, its stability, solubility, and bioactivity are critical factors in its potential use in medical therapies.

Please enquire for more information about (3,5-Diiodo-Tyr5)-LHRH Pyr-His-Trp-Ser-3,5-diiodo-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 including the price, delivery time and more detailed product information at the technical inquiry form on this page

CAS 73644-49-2

(3,5-Diiodo-Tyr5)-LHRH

(3,5-Diiodo-Tyr5)-LHRH Pyr-His-Trp-Ser-3,5-diiodo-Tyr-Gly-Leu-Arg-Pro-Gly-NH2

Ref: 3D-FD108427